April 16, 2018
Last week, I wrote the first part of this series to differentiate induced tissue regeneration (iTR) and geroprotectors. In a nutshell, it is the difference between rejuvenation and regeneration.
April 9, 2018
For the last few weeks, I’ve been having a conversation with a friend and reader about the difference between geroprotection and induced tissue regeneration (iTR). Based on those conversations, it’s clear that I haven’t done a good job of differentiating these two concepts.
April 2, 2018
For more than a decade, the scientific evidence supporting coffee’s health benefits has been mounting. Coffee consumption has been linked to lower rates of Alzheimer’s, liver disease, cardiovascular disease, type 2 diabetes, cancer, and others. Epidemiologically, it’s more than obvious that coffee is geroprotective, an anti-aging therapeutic.
March 26, 2018
I had planned this week to write more about the surprising role that mitochondria play in aging. Recent discoveries in this area have convinced me that aging is not only a treatable and reversible disease, but that treatment and reversal is simpler to accomplish than anyone dared imagine.
March 19, 2018
Two stories hit the web last week, perfectly illustrating the enormous impact of the demographic transition. One covers the human tragedy taking place in Japanese prisons. The other is the slow collapse of the venerable toy retailer Toys ‘R’ Us, which we’ll start with.
March 12, 2018
I’ve spent most of the past week at John Mauldin’s annual Strategic Investment Conference (SIC). Many people believe it is the preeminent event for investors, and the general consensus was that it was the best conference yet.
March 5, 2018
As Yogi Berra famously said, “It’s tough to make predictions, especially about the future.”
February 26, 2018
Many futurists believe that humanity is approaching a period of profound transformation as new technologies deliver new and inexpensive goods and services. Some call this dawning era “the Age of Abundance” because prices—even for goods and services considered luxuries today—will fall dramatically.
February 19, 2018
I recently wrote about nicotinamide riboside, also known as vitamin NR or Niagen. It’s taken years, but NR is finally gaining acceptance in the scientific and healthcare communities as a nutrient with significant anti-aging benefits.
February 12, 2018
The Right to Try (RTT) movement may be our best shot at saving the healthcare system. It may also be your best personal chance at living long enough to benefit from next-generation biotechnologies that will extend healthspans far beyond current limitations.
Simply enter your email below and click SIGN UP!
© 2018 Mauldin Economics, LLC. All rights reserved.
Don't leave your free subscription to Tech Digest on the table! Sign up for the biotech, science, and technology stories that can impact your portfolio.
Technology is king—and not just with health and biotech scientists. Investors who are current on the latest trends and developments stay one step ahead of the markets. In Tech Digest, Patrick Cox delivers the news, data, and analysis you need to know to keep your portfolio (and maybe even yourself) healthy.
Sign up today, and you'll get all the breaking news coming out of the tech industry, with expert analysis only Patrick Cox can provide.
